Pot Stocks Surge as Biden ‘Reschedules’ Marijuana
A change in classification is moving closer to reality. Multistate weed sellers would be the immediate beneficiaries.
Biden Announces ‘Monumental’ Marijuana Rescheduling, DOJ To Take Next Steps
Biden announces plan to reclassify marijuana from Schedule I to III, reversing inequities and removing barriers for Americans. Cannabis stocks rise.
US unveils proposal to ease restrictions on marijuana
The U.S. Justice Department on Thursday unveiled a historic proposal to ease restrictions on marijuana, a rule that if enacted would also enable more research on its medicinal benefits.
Cannabis stocks rally as DOJ proposes reclassifying marijuana
President Biden has reportedly announced a major step in reclassifying marijuana from a Schedule III to Schedule I drug. Read more here.
Biden Says Marijuana Being Reclassified As Schedule III Drug
Under the proposed move, marijuana will be reclassified from a Schedule I drug, according to the Drug Enforcement Agency—which groups it alongside drugs like heroin, LSD and ecstasy—to a Schedule III …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
91% favor reforms as public comments for marijuana rescheduling close
A sixty-day public comment period regarding the proposed move to reschedule marijuana concluded on Monday, with 91% of comments showing support for reforms, according to data compiled by Headset, a …
91% favor reforms as public comment period for marijuana rescheduling ends
The public overwhelmingly supports cannabis reform, with 91% of comments in favor of rescheduling or legalizing marijuana, according to Headset data. Read more here.
US, Canadian Pot Firms Eye Germany for Growth as Market Stagnates at Home
North American cannabis firms, facing prohibitive laws, an overcrowded market and a deeply entrenched illicit sector at home are ramping up investments in Germany after the country partly legalized …
Feds To Weigh 40,000 Marijuana Rescheduling Comments From Governors, Lawmakers, Health Experts And Advocates
Tens of thousands of people and organizations weighed in on the federal government’s marijuana rescheduling proposal ahead of the close of public comment on Monday night. That includes governors, …
Marijuana companies are spending millions in the run up to recreational sales launch
Medical marijuana sales began in Ohio in January 2019. Since then, and through March 25, licensed companies have sold $1.78 billion in cannabis flower and manufactured products. That includes $484.4 …
Why Aurora Cannabis, Tilray Brands, and SNDL Inc. Stocks Lit Up on Tuesday
Weed stocks lit up in response. As of 2 p.m., Aurora Cannabis (NASDAQ: ACB) shares were up 6%, Tilray Brands (NASDAQ: TLRY) was up 6.8%, and SNDL Inc. (NASDAQ: SNDL) was doing best of all, scoring a …
Why Florida medical marijuana companies are pushing so hard for recreational pot
As legal marijuana dispensaries hope Floridians vote in November to allow recreational weed, they face a troubling trend: Right now, their flow of new customers is drying up.
Illegal Marijuana Sales A Problem With No End In Sight
State Taxation and Finance officials have conducted numerous adult use cannabis inspections in Jamestown and Ellicott. So far, they’ve only cited one business, a smoke shop on East Second Street that …
What marijuana reclassification could mean for medical research
The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms.
Recent Comments